Business Context and Reporting Period
This Form 8-K Current Report was filed by Medtronic plc on September 17, 2026. The filing addresses a typographical error discovered in the Prospectus for an Exchange Offer commenced on September 14, 2026. Under this offer, Medtronic is exchanging up to 225,361,295 newly issued shares of MiniMed Group, Inc. ("MiniMed") for outstanding Medtronic Ordinary Shares. The filing serves to correct the description of guaranteed delivery procedures within the Prospectus.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document is a procedural correction regarding a corporate transaction rather than a financial performance report.
Material Changes
The material change disclosed is a correction to the "Guaranteed Delivery Procedures" section of the Exchange Offer Prospectus. The original Prospectus incorrectly stated that an executed notice of guaranteed delivery would expire at 12:00 midnight on the second NYSE trading day after execution. The corrected text clarifies that the guaranteed delivery period expires at 5:00 p.m., New York City time, on the second NYSE trading day after the date of execution.
Guidance, Outlook, and Risks
- Transaction Status: The Exchange Offer remains active. If oversubscribed, Medtronic intends to accept additional shares not to exceed two percent of total outstanding Medtronic Ordinary Shares.
- Investor Action: Investors are urged to read the Prospectus and related documents before making investment decisions. No recommendation is made by Medtronic, MiniMed, or their officers regarding participation.
- Correction Impact: The correction ensures shareholders are aware of the correct deadline (5:00 p.m. vs. midnight) for delivering share certificates or book-entry confirmations following a notice of guaranteed delivery.
Important Facts for Investors to Verify
- Verify the corrected deadline for guaranteed delivery procedures is 5:00 p.m. on the second NYSE trading day after notice execution.
- Confirm the total number of MiniMed shares available for exchange (225,361,295) and the potential 2% oversubscription cap.
- Review the full Prospectus filed on Form S-4 and the Schedule TO for complete terms of the separation and exchange.
- Check the information agent (D.F. King & Co., Inc.) contact details for questions regarding the offer.